China NT Pharma Group Company Limited (HKG:1011)

Hong Kong · Delayed Price · Currency is HKD

0.4000

-0.0050 (-1.23%)

Aug 26, 2026, 3:32 PM HKT

HKG:1011 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	380	553	71	145	171	135
Market Cap Growth	-26.88%	675.38%	-50.91%	-15.27%	26.76%	-40.83%
Enterprise Value	818	895	445	993	1,082	992
Last Close Price	0.40	0.82	0.27	0.55	0.90	0.71

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	13.27	13.27	13.27	13.27	13.27
PS Ratio	9.18	20.57	1.77	17.90	-	0.49
PB Ratio	-6.41	-1.81	-0.17	-0.39	-0.63	-0.52
P/FCF Ratio	-	-	-	3.32	4.78	-
P/OCF Ratio	-	-	-	2.61	4.19	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	19.78	33.29	11.01	122.42	-	3.57
EV/FCF Ratio	-	-	-	22.69	30.19	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-6.53	-1.16	-0.94	-1.02	-3.42	-3.94
Debt / FCF Ratio	-	-	-	8.68	26.06	-
Net Debt / Equity Ratio	-6.23	-1.13	-0.92	-1.01	-3.39	-3.89
Net Debt / EBITDA Ratio	-23.18	-25.13	-27.80	-6.65	-87.43	-14.36
Net Debt / FCF Ratio	-	-55.78	-39.63	8.64	25.87	-6.05
Asset Turnover	0.07	0.07	0.11	0.01	-	0.20
Inventory Turnover	23.39	51.14	-	-	-	2.74
Quick Ratio	0.04	0.02	0.01	0.02	0.05	0.05
Current Ratio	0.05	0.03	0.02	0.02	0.06	0.30
Return on Assets (ROA)	-1.76%	-2.27%	-2.49%	-5.26%	-1.69%	-5.19%
Return on Invested Capital (ROIC)	-	-	-	-	-	-20.20%
Return on Capital Employed (ROCE)	415.40%	4.50%	3.40%	16.70%	16.20%	-157.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-8.38%	-5.24%	-79.63%	-108.91%	-43.79%	-135.74%
FCF Yield	-	-1.12%	-13.80%	30.14%	20.92%	-123.43%
Buyback Yield / Dilution	-81.91%	-133.61%	-10.72%	-25.59%	-0.51%	-0.14%
Total Shareholder Return	-81.91%	-133.61%	-10.72%	-25.59%	-0.51%	-0.14%